GlassScriptPhysician profile
Jacqueline A Rendon
NPI 1881280964
$1,552.61
in general payments reported to CMS, 2019-2025
10 companies · $489 in 2025
The $489 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $148 · 2022: $36.10 · 2023: $549 · 2024: $330 · 2025: $489.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,294 · Education: $74.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,293.97 |
| Education | $74.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $482.50 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $462.05 | 2023-2025 | |
| Exeltis, USA INC. | $325.76 | 2022-2025 | Slynd, Twirla |
| Astrazeneca Pharmaceuticals LP | $124.52 | 2021 | |
| Pfizer INC. | $57.00 | 2023-2024 | |
| Hologic Sales and Service, LLC | $24.83 | 2025 | Thinprep 2000 Processor, Aptima |
| Evofem Biosciences, INC. | $23.03 | 2021 | |
| Lilly USA, LLC | $18.46 | 2022 | |
| Acella Pharmaceuticals, LLC | $17.38 | 2025 | NP Thyroid 60 |
| Shield Therapeutics INC | $17.08 | 2023 | Accrufer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacqueline Rendon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.